Table 4 Distribution of COVID-19 outcomes according to the individual variables selected
From: Factors associated with death in confirmed cases of COVID-19 in the state of Rio de Janeiro
Variables | Death | Non-death | Statistic parameter | P-value | ||
|---|---|---|---|---|---|---|
n | % | n | % | Chi-square | ||
Age group | 40,056 | 0.000 | ||||
0–9 years | 60 | 0,3% | 5045 | 2.2% | – | – |
10–19 years | 34 | 0,2% | 7444 | 3.3% | – | – |
20–29 years | 210 | 1,2% | 30,216 | 13.4% | – | – |
30–39 years | 603 | 3,3% | 53,051 | 23.5% | – | – |
40–49 years | 1400 | 7,7% | 50,513 | 22.4% | – | – |
50–59 years | 2526 | 14,0% | 38,203 | 16.9% | – | – |
60–69 years | 4154 | 23,0% | 22,880 | 10.1% | – | – |
70–79 years | 4425 | 24,5% | 10,848 | 4.8% | – | – |
80 years or older | 4622 | 25,6% | 6190 | 2.7% | – | – |
Sex | 521 | 0.000 | ||||
Female | 8003 | 44,3% | 119,674 | 53.1% | – | – |
Male | 10,073 | 55,7% | 105,759 | 46.9% | – | – |
Race/color | 794 | 0.000 | ||||
Brown | 4480 | 24,8% | 75,682 | 33.6% | – | – |
Asian | 182 | 1,0% | 11,693 | 5.2% | – | – |
White | 5041 | 27,9% | 74,454 | 33.0% | – | – |
Indigenous | 11 | 0,1% | 480 | 0.2% | – | – |
Black | 1479 | 8,2% | 14,323 | 6.4% | – | – |
Missing | 6883 | 38,08% | 48,801 | 21.6% | – | – |
Presence of signs and symptoms | – | – | ||||
Fever | 8723 | 48,3% | 84,379 | 37.4% | 830 | 0.000 |
Cough | 8908 | 49,3% | 99,526 | 44.1% | 178 | 0.000 |
Headache | 503 | 2,8% | 32,517 | 14.4% | 1934 | 0.000 |
Sneezing | 10 | 0,1% | 1626 | 0.7% | 110 | 0.000 |
Odynophagia | 1560 | 8,6% | 41,237 | 18.3% | 1078 | 0.000 |
Dyspnea | 10,204 | 56,5% | 42,172 | 18.7% | 14,118 | 0.000 |
Runny nose | 233 | 1,3% | 17,906 | 7.9% | 1074 | 0.000 |
Diarrhea | 143 | 0,8% | 12,658 | 5.6% | 781 | 0.000 |
Muscle pain | 803 | 4,4% | 22,212 | 9.9% | 571 | 0.000 |
Loss of smell | 194 | 1,1% | 21,570 | 9.6% | 1483 | 0.000 |
Loss of taste | 99 | 0,5% | 15,379 | 6.8% | 1106 | 0.000 |
Presence of comorbidities | – | – | ||||
Cardiovascular disease | 6163 | 34,1% | 19,682 | 8.7% | 21,646 | 0.000 |
Diabetes mellitus | 4341 | 24,0% | 11,159 | 5.0% | 26,588 | 0.000 |
Chronic kidney disease | 923 | 5,1% | 1280 | 0.6% | 11,461 | 0.000 |
Chronic respiratory disease | 845 | 4,7% | 5473 | 2.4% | 346 | 0.000 |
Immunodeficiency/ immunosuppression | 464 | 2,6% | 2063 | 0.9% | 2153 | 0.000 |
Total | 18,076 | 7,4% | 225,433 | 92.6% | – | – |